Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Internal Medicine Journal
|
August 13, 2019
Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial
Matthew Ku, Ali Bazargan, Constantine Tam
Internal Medicine Journal
|
January 19, 2021
Feasibility of an online cognitive rehabilitation programme in patients with a haematological malignancy undergoing autologous stem cell transplantation
Matthew Ku, Priscilla Gates, Steffi Renehan
Journal of Clinical Medicine
|
November 14, 2023
T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma-An Update
Shalini Balendran, Constantine Tam, Matthew Ku
Case Reports in Oncology
|
November 30, 2020
Acquired Pure Red Cell Aplasia Associated with Chronic Myelomonocytic Leukemia: Too Many of One, Not Enough of the Other
Jose Filipe Gonsalves, Ali Bazargan, Matthew Ku
Blood Reviews
|
August 30, 2016
Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab
Matthew Ku, Geoff Chong, Eliza A Hawkes
Leukemia & Lymphoma
|
July 12, 2013
Effective treatment of Waldenström macroglobulinemia associated pure red cell aplasia with standard antilymphomatous chemotherapy
Matthew Ku, Ali Bazargan, Harshal Nandurkar, et al.
International Journal of Pediatric Otorhinolaryngology
|
September 6, 2020
An extended release ciprofloxacin/dexamethasone hydrogel for otitis media
Matthew Ku, Shirley Cheung, William Slattery, et al.
Lancet (London, England)
|
October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' reply
Jeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Frontiers in Human Neuroscience
|
January 3, 2022
Magnetoencephalography Studies of the Envelope Following Response During Amplitude-Modulated Sweeps: Diminished Phase Synchrony in Autism Spectrum Disorder
Timothy P L Roberts, Luke Bloy, Song Liu, et al.
Leukemia & Lymphoma
|
May 16, 2022
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies
Joel Wight, Matthew Ku, Melissa Garwood, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Internal Medicine Journal
|
August 13, 2019
Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial
Matthew Ku, Ali Bazargan, Constantine Tam
Internal Medicine Journal
|
January 19, 2021
Feasibility of an online cognitive rehabilitation programme in patients with a haematological malignancy undergoing autologous stem cell transplantation
Matthew Ku, Priscilla Gates, Steffi Renehan
Journal of Clinical Medicine
|
November 14, 2023
T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma-An Update
Shalini Balendran, Constantine Tam, Matthew Ku
Case Reports in Oncology
|
November 30, 2020
Acquired Pure Red Cell Aplasia Associated with Chronic Myelomonocytic Leukemia: Too Many of One, Not Enough of the Other
Jose Filipe Gonsalves, Ali Bazargan, Matthew Ku
Blood Reviews
|
August 30, 2016
Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab
Matthew Ku, Geoff Chong, Eliza A Hawkes
Leukemia & Lymphoma
|
July 12, 2013
Effective treatment of Waldenström macroglobulinemia associated pure red cell aplasia with standard antilymphomatous chemotherapy
Matthew Ku, Ali Bazargan, Harshal Nandurkar, et al.
International Journal of Pediatric Otorhinolaryngology
|
September 6, 2020
An extended release ciprofloxacin/dexamethasone hydrogel for otitis media
Matthew Ku, Shirley Cheung, William Slattery, et al.
Lancet (London, England)
|
October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' reply
Jeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Frontiers in Human Neuroscience
|
January 3, 2022
Magnetoencephalography Studies of the Envelope Following Response During Amplitude-Modulated Sweeps: Diminished Phase Synchrony in Autism Spectrum Disorder
Timothy P L Roberts, Luke Bloy, Song Liu, et al.
Leukemia & Lymphoma
|
May 16, 2022
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies
Joel Wight, Matthew Ku, Melissa Garwood, et al.
Page
of 8